We evaluated IL-17A, TNFα, IL-1β protein levels in saliva of COVID-19 patients with different severities, and found that among these cytokines, IL-17A was associated with COVID-19 severity and poor patient survival outcomes. The gene discussed is IL1B; the disease is COVID-19.